Professional Grade Phospho-eef2k (ser366) Polyclonal Antibody System [H6fdhe8C]

Phospho-EEF2K (Ser366) Antibody: A Key Tool for Cancer Research

The Professional Grade Phospho-eef2k (ser366) Polyclonal Antibody System [H6fdhe8C] is a vital research tool designed for the study of the eEF2K protein, a crucial component in the calmodulin-mediated signaling pathway. This antibody is specifically engineered to recognize and bind to the phosphorylated Ser366 site on the eEF2K protein, making it an essential resource for researchers investigating protein synthesis regulation and its role in cancer development. Key features of this antibody include its high specificity for human and rat samples, as well as its applications in Western blot (WB) and immunohistochemistry (IHC-p) techniques.

• High specificity for eEF2K phosphorylated at Ser366
• Applications in WB and IHC-p
• Reactivity with human and rat samples

Product Specifications and Technical Details

This antibody is produced using rabbit immunoglobulin G (IgG) and is characterized by its high purity and affinity purification process. The immunogen used in its production is a synthesized peptide derived from the human eEF2K protein, ensuring the highest level of specificity. The antibody is available in a concentration of 1 mg/mL in a phosphate buffered solution, pH 7.4, containing stabilizers and protein protectants to maintain its stability. Technical specifications include:

• Isotype: IgG
• Host: Rabbit
• Calculated MW: 82 kDa
• Observed MW: 105 kDa
• Cellular Localization: Cytosol, cytoplasm, dendritic spine, postsynaptic density

Applications and Benefits of Phospho-EEF2K (Ser366) Antibody

The Phospho-EEF2K (Ser366) Antibody is a versatile tool for researchers in the fields of cancer, epigenetics, and nuclear signaling. Its ability to detect and quantify the phosphorylated form of eEF2K makes it particularly valuable for studying the role of this protein in various cellular processes, including protein synthesis and cell division. This antibody is ideal for both academic research and pharmaceutical development, offering numerous benefits:

• Enables detailed analysis of eEF2K phosphorylation in various cellular contexts
• Facilitates the study of protein synthesis regulation and its implications in cancer
• Supports the development of targeted therapies for cancer treatment

Whether you are a researcher in academia or a scientist in the pharmaceutical industry, this antibody is a valuable addition to your research toolkit.